Prognostic scoring models of mortality in a real-life ICU patient cohort have poor value in guiding decisions concerning treatment restrictions of patients with COPD and acute respiratory failure.
Sep 2026· Respiratory medical research· Vol 90, pp.
101328
· 0 citations· 13 references
Medicine
TL;DR
Clinical parameters as well as prognostic and physiology scoring systems predicting mortality in patients with AECOPD treated in the authors' ICU showed poor or no discriminative quality.
Abstract
Background
To improve the assessment of which patients would benefit from intensive care treatment and to facilitate end-of-life discussions, we evaluated the discriminative value of several scoring systems predicting the mortality of patients with an Acute Exacerbation of COPD (AECOPD) in our population.
Materials And Methods
We used electronic patient data systems to recover all parameters associated with mortality from patients with AECOPD admitted to our ICU. Several acute physiology scores and prognostic scoring systems (BAP-65, modified DECAF, eMRCD and the CAOS score) were evaluated. The area under the receiver operating characteristic curve (AUROC) was used to test for discriminative quality in predicting in-hospital mortality.
Results
A total of 159 AECOPD admissions were included. Forty-seven patients (29.6%) died in hospital. No significant differences were found in demographic features, severity of chronic illness, physical fitness and co-morbidity between in-hospital survivors and non-survivors. Regarding the severity of acute illness and prognostic models, only Apache II, -IV, CAPS and the CAOS score proved to be significantly different between groups. When tested for discriminative quality, however, none of the acute physiology scores or prognostic models tested proved to be of discriminative value (AUROCs of 0.532-0.670).
Conclusion
We evaluated clinical parameters as well as prognostic and physiology scoring systems predicting mortality in patients with AECOPD treated in our ICU. The results showed poor or no discriminative quality. Caution should be used when implementing prognostic scoring systems for patients with AECOPD not validated for the target population.
Background/Objectives: Early risk stratification is essential in pulmonary embolism (PE), but a simple tool integrating routinely available clinical and laboratory variables is lacking. We aimed to develop a simple score for predicting 30-day mortality in patients presenting to the emergency department (ED) with PE. Me...
Shin Young Park, I. Park, H. Chung et al.· Diagnostics· 0 citations
Background: The acute physiology and chronic health evaluation II (APACHE II) score is widely used to assess illness severity and predict mortality in critically ill patients. This study evaluated its usefulness for mortality prediction in a respiratory intensive care unit (RICU).
Methods: A prospective observational s...
Muralidhar Anakapalli, H. Mangu, Pawan B. Nanaiah et al.· International Journal of Res...· 0 citations
Aims: Accurate prediction of mortality in critically ill patients is important for clinical decision-making and resource allocation in intensive care units (ICUs). This study aimed to evaluate factors associated with ICU mortality, with particular emphasis on APACHE II score and lactate-to-albumin ratio (LAR).Methods:...
Seval Kılbasanlı· Journal of Health Sciences a...· 0 citations
Elevated CONUT scores are independently associated with adverse outcomes in emergency department sepsis patients, serving as a simple prognostic indicator for early risk stratification.
Sue Zhao, Shuang Wu, Ying-Jie Su et al.· Frontiers in Nutrition· 0 citations
Background: APACHE II is an abbreviation for the Acute Physiology and Chronic Health Evaluation scoring system that is frequently used to study the possibility of disease progression and predict the mortality risk in patients with critical illness.Objectives: To analyze the outcomes of the Intensive Care Unit (ICU) at...
W. Ali, Tasneem Alkhalidy, Elaf Al Janabi et al.· Journal of the Faculty of Me...· 0 citations
Background: Mortality risk among patients with severe COVID-19 is determined by interacting clinical, respiratory and systemic factors. This study evaluated whether routinely available respiratory and biomarker information could provide incremental prognostic information in a cohort of patients treated with convalescen...
Gianluca Gessoni, S. Valverde, F. Gessoni et al.· Asian Journal of Research in...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.